Atlas Trials

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

Clinical trial NCT06750783 · RECRUITING

Trial details

NCT number
NCT06750783
Sponsor
Beijing Tsinghua Chang Gung Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Prediabetic State (IGT)
Start date
2024-12-31
Primary completion
2026-03-31
Enrollment
398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.